Building Resilient Supply Chains, Revitalizing American Manufacturing, and Fostering Broad-Based Growth

Jun 19, 2021 | Your Source

The COVID-19 pandemic and resulting economic dislocation revealed long-standing vulnerabilities in our supply chains. The pandemic’s drastic impacts on demand patterns for a range of medical products including essential medicines wreaked havoc on the US healthcare system. As the world shifted to work and learn from home, it created a global semiconductor chip shortage impacting automotive, industrial, and communications products, among others. In February, extreme weather events—exacerbated by climate change—further exacerbated these shortages. In recent months the strong US economic rebound and shifting demand patterns have strained supply chains in other key products, such as lumber, and increased strain on US transportation and shipping networks.

On February 24, 2021, President Biden signed Executive Order (E.O.) 14017, “America’s Supply Chains,” in which he directed the US government to undertake a comprehensive review of critical US supply chains to identify risks, address vulnerabilities and develop a strategy to promote resilience. When the President signed the order, he invoked an old proverb: “For want of a nail, the shoe was lost. For want of a shoe, the horse was lost.” And on, and on, until the kingdom was lost. Small failures at even one point in supply chains can impact America’s security, jobs, families, and communities.

To undertake this comprehensive review, the Biden Administration established an internal task force spanning more than a dozen Federal Departments and Agencies. Administration officials consulted with hundreds of stakeholders from labor, business, academic institutions, Congress, and US allies and partners to identify vulnerabilities and develop solutions. Federal Departments and Agencies received hundreds of written submissions in response to requests for public input into the supply chain initiative. Dozens of experts across the interagency have been conducting detailed studies of US supply chains for critical products and developing policies that will strengthen resilience.

The initial set of reviews of the supply chains of four critical products—semiconductor manufacturing and advanced packaging, large capacity batteries, critical minerals and materials, and pharmaceuticals and active pharmaceutical ingredients (APIs)—is now available. These reviews were provided by the Departments of Commerce, Energy, Defense, and Health and Human Services, respectively. Read more:

Share This